A Study of Quetiapine for the Treatment of Mood Disorders in Adolescents

PHASE3CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

June 30, 2003

Primary Completion Date

April 30, 2006

Study Completion Date

April 30, 2006

Conditions
Mood Disorders
Interventions
DRUG

quetiapine

100mg of quetiapine on day 1 and titrated to a maximum dose of 400mg by day 4, with flexible dosing to 600mg by day 28. The total duration of treatment will be 84 days (12 weeks).

Trial Locations (1)

45267

University of Cincinnati Medical Center, Cincinnati

Sponsors

Collaborators (1)

All Listed Sponsors
lead

University of Cincinnati

OTHER

collaborator

AstraZeneca

INDUSTRY